Author
R.D. Pinnock
Also Known As
Pinnock, R., R D Pinnock, R D. Pinnock, R PINNOCK, R. D. PINNOCK, R. D. Pinnock, R. PINNOCK, R. Pinnock, R.D Pinnock, R.D. Pinnock
60
Publications
3.4K
Citations
33
H-Index
58
Concepts
All Affiliations
| # | Concept | H-Index | Publications | Citations |
|---|---|---|---|---|
1 | Medicine | 24 | 30 | 2.3K |
2 | Social Sciences | 15 | 16 | 1.1K |
3 | Health Sciences | 3 | 3 | 155 |
4 | Biochemistry | 3 | 3 | 290 |
5 | Biology | 1 | 1 | 23 |
R.D. Pinnock
×
40
Publications
3.1K
Citations
31
H-Index
| Year | Citations | |
|---|---|---|
Development of a class of selective cholecystokinin type B receptor antagonists having potent anxiolytic activity. Joel W. Hughes, P. Boden, B. Costall, Proceedings of the National Academy of Sciences Molecular PharmacologyMaze TestPotent Anxiolytic ActivityCholecystokinin Type BPharmacological Study | 1990 | 504 |
2002 | 240 | |
1984 | 165 | |
2002 | 148 | |
1985 | 127 | |
1984 | 118 | |
2003 | 110 | |
1999 | 109 | |
2000 | 97 | |
1999 | 90 |
Page 1
Page 1